Netherlands· NL-187f43b4d3d3
Mebutan 500 mg, tabletten
A nabumetone product containing nabumeton, registered in Netherlands by Viatris Healthcare B.V.. The same ATC class is registered in 14 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Nabumetone is registered in 14 of 19 countries.
Countries holding a registration under ATC M01AX01 (nabumetone), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 8 of them publish a price we can compare per daily dose
Nabumetone · ATC M01AX01
14 / 19 countries
- Belgiumprice
- Canada
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of nabumetone costs, country by country.
Normalised to the WHO defined daily dose (1 g), the median price runs from $0.37 in France to $0.73 in Italy — a ×2.0 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Nabumetone · price per daily dose (1 g)
USD · FX 28 Sept 2026
- IT Italy$0.73
- FR France$0.37
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- NABUMETON
- Manufacturer
- Viatris Healthcare B.V.
- Country
- Netherlands (NL)
- ATC code
- M01AX01
- ATC class
- Nabumetone
- Defined daily dose
- 1 g, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id12602
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
289 interactions on record for nabumetone.
Graded by severity as the source publishes them — 57 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Nabumetone · interactions on record
289 records
- 57 severe
- 142 moderate
- 4 minor
- 86 info
Most severe, free to view
- DicoumarolB01AA01severe
- WarfarinB01AA03severe
- DalteparinB01AB04severe
- EnoxaparinB01AB05severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Nabumetone in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesNabumetoneAmerican Health Packaging
- FinlandNabumeton Bmm PharmaBMM Pharma AB
- IrelandNabumetone Tillomed 500 mg Film-coated TabletsTillomed Pharma GmbH
- BelgiumGambaran 500 mgViatris Healthcare
- SwedenRelifex 500 mg Filmdragerad tablettViatris AB
- NorwayRelifexViatris AS
- FranceNABUCOM 500 mg, comprimé pelliculéARROW GENERIQUES
- IcelandRelifexViatris ApS
Authorised across Europe · EMA
The same active substance is authorised in 17 EEA countries. Names it is sold under:
- Belgium · Gambaran, Nabumeton Tillomed
- Germany · Relifex
- Estonia · Relifex
- Spain · Relif
- France · Nabucom
- United Kingdom (Northern Ireland) · Nabumetone Accord-Uk, Nabumetone Kent Pharma Uk
- Greece · Akratol, Nabuton
- Hungary · Relifex
- Ireland · Nabumetone Tillomed, Relifex
- Iceland · Relifex
- Italy · Nabuser
- Lithuania · Relifex
- Luxembourg · Gambaran
- Latvia · Relifex
- Norway · Relifex
- Poland · Nabuton Vp
- Sweden · Relifex
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/54876571-0132-4150-8205-72c2133a4fb6 GET /v1/drugs/54876571-0132-4150-8205-72c2133a4fb6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Filmomhulde tablet",
"route": "Oraal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h12602_smpc.pdf",
"strength": null,
"atc_label": "Nabumetone",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg12602",
"excipients": [
"CARMINEZUUR (E 120)",
"CARNAUBAWAS (E 903)",
"CELLULOSE, MICROKRISTALLIJN (E 460(i))",
"HYPROMELLOSE (E 464)",
"IJZEROXIDE GEEL (E 172)",
"LIQUID CARAMEL FLAVOUR H & R 47001 (RI)",
"MACROGOL",
"MAGNESIUMSTEARAAT (E 470b)",
"NATRIUMLAURILSULFAAT",
"NATRIUMZETMEELGLYCOLAAT",
"SACCHAROIDE NATRIUM X-WATER (E 954)",
"TALK (E 553b)",
"TITAANDIOXIDE (E 171)"
],
"substances": [
"NABUMETON"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h12602.pdf",
"authorised_at": "1991/04/26",
"procedure_number": null,
"dispensing_status": "Uitsluitend recept",
"registration_number": "12602",
"additional_monitoring": "N"
}See everything about nabumetone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.